Khevna Khona is a 33-year-old vegetarian woman based in Ardmore, Pennsylvania, who has been trying to conceive for over two years and joined the Ferta programme in January 2026 presenting with three interlocking issues: androgen-dominant PCOS (confirmed by elevated testosterone alongside hirsutism and jaw-line acne), functional hypothyroidism with poor T4-to-T3 conversion (TSH had risen to 4.39 before treatment began), and a longstanding hypersensitive gut with a childhood history of severe constipation. Her care has progressed through five structured phases — an initial gut-reset and dairy-elimination phase, a thyroid-decision phase that introduced 25 mcg levothyroxine in late February 2026, a gut re-inoculation phase reintroducing fermented foods, a diet-refinement phase correcting persistent protein shortfalls, and the current Phase 5, which layered in iron, selenium, and electrolyte support after April labs revealed a 51% drop in testosterone (96→47→40 ng/dL) alongside a stalled, low-normal iron picture and a flat salivary cortisol curve. Throughout, her fertility-relevant markers have moved favourably — testosterone has normalized, fasting glucose and HbA1c are excellent (78 mg/dL and 5.3%), and ferritin turned out to be healthy (74 ng/mL) once finally tested, reframing what looked like iron deficiency as more likely inflammation-driven iron sequestration (CRP 2.1, eosinophils 5%) tied to dairy reintroduction. Her most recent labs (April–June 2026) show a still-flat FT3 (3.0 pg/mL) despite improving TSH, a normal Reverse T3 (17.7 ng/dL) and negative thyroid antibodies that rule out an autoimmune or conversion-blockage explanation in favour of simple underdosing, a persistently suppressed night-time cortisol point even as the rest of her cortisol curve has normalized, an unexpectedly low fasting insulin (2.2 uIU/mL) that is most likely a sign of genuinely improved insulin sensitivity rather than dysfunction, and a single ambiguous progesterone reading (0.42 ng/mL) whose cycle-day timing is still unconfirmed — making a properly-timed luteal-phase progesterone retest the single highest-priority open item in her case as she continues working toward pregnancy. the following is her latest treatment plan- analyse critically and scienctifically and suggest whats missing and what you would add or remove FERTA PROTOCOL Phase WL-1 — Khevna Khona Duration: 8 weeks (reassess and progress to Phase WL-2 based on retests) Goals: Sustainable fat-mass reduction via body composition improvement (not caloric restriction) • Preserve/improve fertility readiness (ovulatory hormone balance, endometrial support) • Protect and improve insulin, thyroid, and inflammatory markers while losing weight • Maintain vegetarian protein adequacy (≥80g/day) throughout Clinical basis for this approach: Khevna's fasting insulin is LOW (2.2 uIU/mL, range 2.6–24.9), not high. This rules out a standard PCOS calorie-restriction/insulin-resistance weight-loss model. A caloric deficit imposed on an already-low-insulin, borderline-low-FT3 (3.0 pg/mL) system risks further suppressing both metabolism and ovulatory hormone production. This protocol therefore targets weight loss through body composition change (muscle gain + fat loss at maintenance-to-mild-deficit calories), not aggressive restriction — the evidence-based approach for a normal-BMI (24), fertility-focused, insulin-sensitive patient. 1. Dietary Guidance Foods to Include Category Specific recommendations Protein 75–90 g/day minimum, protein-anchored at every meal (this is the single highest-leverage lever for both weight loss and egg quality). Sources: dal/lentils (18g/cup), chickpeas/rajma (15g/cup), tofu (10g/100g), paneer (cooked, capped at 1×/week — see Section on inflammation below), Greek-style hung curd (15–17g/150g), moong/chana sprouts, pumpkin seeds, peanut/almond butter, pea protein powder (1 scoop/day if needed to close gaps). Protein at this level increases satiety (via PYY/GLP-1 signalling) and preserves lean mass during any caloric adjustment — directly supporting body-composition-driven weight loss rather than muscle loss. Fibre (soluble + insoluble) 25–30 g/day from vegetables, legumes, and whole grains. Soluble fibre (oats, okra, flax) slows gastric emptying and blunts post-meal glucose swings; both support satiety without restricting calories aggressively. Daily: 1–2 tbsp ground flaxseed (also lignan source — supports estrogen metabolism). Vegetables & Fruits 2–3 cups non-starchy vegetables daily (lauki, zucchini, capsicum, beans, tinda, ridge gourd, cooked leafy greens). 1–2 servings whole fruit daily (berries, apple, pear, kiwi, pomegranate — lower glycemic load, antioxidant-dense, pomegranate specifically supportive of endometrial blood flow). Avoid fruit juice. Fats & Oils Ghee 1–2 tsp/day (supports steroid hormone synthesis — cholesterol is the direct precursor to progesterone/estrogen), cold-pressed mustard or sesame oil for cooking, 4–5 walnuts/day (ALA omega-3), ¼ avocado 3–4×/week if accessible. Do not adopt a low-fat approach — adequate dietary fat is required for ovarian steroidogenesis and fat-soluble vitamin (D, K2) absorption. Grains (complex, lower-glycemic) Millets preferred over rice/wheat for most meals: jowar, bajra, ragi, little millet. These have a lower glycemic index and higher fibre/mineral density than polished rice or wheat flour, supporting both glucose stability and the existing thyroid-friendly, gluten-light pattern already in place. Rice reserved for dinner only if needed. Fermented Foods 2 servings/day: idli/dosa batter (fermented), homemade curd, buttermilk (chaas). Supports gut microbiome diversity, which has direct downstream effects on estrogen metabolism via the gut “estrobolome” and on systemic inflammation (relevant given CRP 2.1). Selenium & Zinc food sources 2–3 Brazil nuts daily (selenium, supports T4→T3 conversion) and 1 tbsp pumpkin seeds daily (zinc, supports progesterone synthesis and ovarian function) — continue as already established. Iron + Vitamin C pairing Continue pairing iron-containing foods (lentils, cooked spinach, fortified grains) with a vitamin C source (lemon, tomato, bell pepper, orange) at the same meal for 3–4× better non-heme absorption — maintenance-level priority given ferritin is already healthy (74 ng/mL). Foods to Avoid / Reduce Refined sugar and sweetened beverages — eliminate. These provide rapid glucose without satiety, working against both weight management and the low-insulin pattern by creating sharp insulin demand spikes followed by crashes. Wheat/refined flour products (maida, white bread, regular roti) — minimize; continue using millets as the primary grain, consistent with existing protocol. Paneer — reduce to 1×/week (cooked form only), not full elimination. This corrects the prior over-restriction: a full 6-week elimination would compromise vegetarian protein intake on a hypothesis (dairy → eosinophilia) that isn't firmly established from a single 9-month-apart lab comparison. Stepping down frequency while monitoring CRP/eosinophils on retest is the better-evidenced approach. Fried and ultra-processed snack foods — minimize; these contribute to the CRP 2.1 inflammatory picture without nutritional return. Alcohol — avoid entirely given active conception attempts (no safe level established in early pregnancy, and alcohol affects both implantation receptivity and sperm parameters if applicable to partner). Excess caffeine — cap at 1 cup coffee or 2 cups tea daily; avoid after 2 PM given the existing unresolved night-cortisol/sleep-onset question. Key Practices Fasting window: 12 hours — last meal by 7 PM, first meal after 7 AM (continues existing protocol; do NOT extend beyond 12 hours — longer fasting windows risk further suppressing an already-low fasting insulin and can blunt thyroid conversion). Eat 4–5 meals/snacks at regular 3–4 hour intervals — critical given the low-insulin finding; long gaps reduce the glucose stimulus needed for normal insulin secretion and can worsen energy crashes. Protein-first meal sequencing: eat protein and vegetables before carbohydrates within each meal — blunts post-meal glucose excursion without requiring calorie counting. Chew thoroughly, eat without screens — supports vagal/parasympathetic tone during digestion, relevant given the existing HPA-axis focus in her broader protocol. No fewer than 1,600–1,800 kcal/day even on lower-intake days — a hard floor. Going below this risks the exact mechanism (hypothalamic energy-deficit signalling suppressing GnRH pulsatility) that can impair ovulation, directly working against the fertility goal. 2. Supplement Protocol This list is weight-loss/fertility-focused and assumes continuation of her existing core protocol (myo-inositol, omega-3, NAC, vitamin D3+K2, magnesium, selenium — see prior Phase 5 / revised treatment plan documents). Items below are the specific additions or retimings relevant to this phase's goals. Supplement Dosage Timing Duration Myo-inositol + D-chiro-inositol (40:1) 2000 mg twice daily AM + PM with food Daily, ongoing — improves insulin signalling at the ovarian/cellular level and supports oocyte quality independent of serum insulin level; meta-analytic evidence supports improved ovulation rates and modest weight/BMI improvement in PCOS-phenotype patients (Unfer et al., 2017) Chromium picolinate 200 mcg/day With lunch 8 weeks, then reassess with fasting insulin recheck — supports insulin receptor signalling; relevant adjunct given her low-insulin, vegetarian-diet context where chromium intake is commonly marginal L-Carnitine 1–2 g/day With breakfast or pre-activity Daily, ongoing — facilitates fatty-acid transport into mitochondria for beta-oxidation (fat-burning at the cellular level) and supports oocyte mitochondrial energy metabolism; dual benefit for weight loss and egg quality CoQ10 (ubiquinol) 400 mg/day With breakfast + fat Daily, ongoing — mitochondrial ATP support for both metabolic rate and oocyte quality in women >30 (Ben-Meir et al., 2015) Curcumin (phytosome form) 500 mg twice daily With meals containing fat or black pepper 8 weeks — anti-inflammatory, directly targets CRP 2.1; chronic low-grade inflammation independently impairs both insulin signalling and endometrial receptivity Magnesium glycinate 400 mg/day (200 AM + 200 PM, PM dose 60 min before bed) Split dosing Daily, ongoing — cofactor for >300 enzymatic reactions including glucose metabolism and ATP-dependent insulin secretion; serum Mg already low-normal at 1.9 mg/dL Vitamin B6 (P5P form) 25–50 mg/day With breakfast Daily through the luteal phase of conception-attempt cycles — cofactor for progesterone synthesis, supports corpus luteum function Zinc picolinate 15 mg/day (maintenance, not corrective — serum zinc already healthy at 81 ug/dL) With dinner, away from iron/calcium Daily, ongoing — supports progesterone production and egg quality Discontinue or Avoid During This Phase Any appetite-suppressant or stimulant-based weight-loss aid (including high-dose green tea extract, synephrine, or similar) — these elevate cortisol/catecholamines and would work directly against both the unresolved night-cortisol issue and ovulatory hormone balance. Berberine or other strong insulin-sensitizing agents beyond what's already in the stack — her insulin is already low; adding agents that further reduce insulin secretion or demand is contraindicated here, unlike in a typical PCOS hyperinsulinemia protocol. High-dose licorice root beyond the existing AM-only 500mg — potassium is already low-normal (4.3 mmol/L); weight-loss protocols sometimes use licorice for cortisol modulation, but escalating dose here carries real hypokalemia risk. 3. Exercise Recommendations Weekly Target: 4–5 hours total activity per week, structured as below. This is intentionally body-composition-focused (preserve/build lean muscle while reducing fat mass) rather than a high-volume calorie-burn approach — muscle is metabolically active tissue and is the primary lever for sustainable fat loss without further suppressing an already-borderline metabolic/hormonal picture. Recommended Types Type Frequency / Volume Rationale Resistance training 3×/week, 35–45 min, moderate intensity — compound movements prioritized (squats, rows, glute bridges, presses) over high-rep isolation work Builds/preserves lean muscle mass, which raises resting metabolic rate — the single most evidence-backed lever for sustainable fat loss; also directly improves insulin sensitivity via increased GLUT4 expression in muscle tissue, supporting (not fighting) her current low-insulin status by improving glucose disposal efficiency Walking (zone 1–2 cardio) 8,000–10,000 steps/day, ideally with morning outdoor light exposure Fat oxidation occurs preferentially at low intensities; morning light exposure additionally supports circadian cortisol entrainment, relevant to the existing night-cortisol question Restorative yoga / mobility 2–3×/week, 20–30 min Supports pelvic circulation, parasympathetic tone, and the existing back-pain management plan; does not add cortisol/catecholamine burden Avoid High-Intensity Interval Training (HIIT) or any session sustaining high heart-rate zones — acutely elevates cortisol and catecholamines, which actively suppress insulin secretion (working against an already-low value) and can disrupt the ovulatory LH pulse pattern if done in excess, particularly during the follicular phase. Fasted intense training — if a resistance session falls in the morning, a small pre-workout snack (banana + nut butter, or similar) is required; training fasted at intensity raises catecholamines further and works against the goal of supporting, not suppressing, insulin secretion. Any net weekly caloric deficit driven primarily through exercise volume increases rather than body composition change — large deficits from cardio volume are the mechanism most associated with hypothalamic suppression of reproductive hormones in active women; this protocol favors building muscle at a mild-to-neutral calorie balance over aggressive deficit-via-exercise. Exercise Plan / Upgrades Progression criteria: increase resistance training load/volume only once (a) no back-pain flare has occurred for 4 consecutive weeks, and (b) the Section 11 retest (8 weeks) shows stable-to-improving FT3 and fasting insulin trending toward range. If both are met, resistance frequency can move to 4×/week; if either is not met, hold at current volume and prioritize the metabolic-recovery items in Sections